drugset / Trial / NCT02601235

Efficacy and Safety of Pediatric Drugs in Nasal Congestion

NCT02601235

Phase 3 Completed 292 enrolled EMS
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of the Naridrin in improving nasal congestion.

Timeline

Start
2018-01-16
Primary completion
2018-08-03
Completion
2019-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexpanthenol Small molecule Intranasal
Subject Naphazoline Small molecule Intranasal
Comparator Oxymetazoline Other / unclassified Intranasal
Subject PYRILAMINE Small molecule Intranasal

Indications